Making any medicine precision medicine: Welcome, InsightRX!
We’re proud to announce our participation in InsightRX's $10M Series A funding round to support their mission of individualizing drug treatment at the point of care.
Putting patients in the driver’s seat of their data: A Q&A with Ciitizen CEO Anil Sethi
In honor of his late little sister Tania, Anil Sethi founded Ciitizen to help kill cancer in our lifetime—and give patients power over their health outcomes along the way. We’re thrilled to have him join us at Rock Health Summit next month, where he’ll dive into how empowering patients with their health data will change the face of life-saving clinical research and development. We sat down with Anil to get his take on building a business around making personal health records portable.
Innovation and collaboration in the new age of consumer healthcare: A Q&A with GSK
As consumers increasingly take control of their own health and wellness, they drive market demand more directly. Devices, apps, and services are being created and tailored to meet their needs, enabling consumers to actively engage in health and wellness decision-making. To dig a little deeper beneath the surface of how industry players are adapting to this shift, we caught up with experts on the inside at GSK Consumer Healthcare, a Rock Health partner.
What it takes to build a successful enterprise-startup partnership in digital health: Part 2
By now it’s no secret most digital health companies achieve growth and scale through enterprise organizations, such as health systems, payers, and pharmaceutical companies. But in increasingly crowded spaces like digital mental health, standing out from the pack is paramount to success. In our latest podcast episode, leaders from Kaiser Permanente Washington and mental health startup Ginger opened up about what brought their two companies together and how they cultivated a trusting relationship.
7 reasons why you should attend Rock Health Summit 2019
‘Tis the season of startup pitches, inspirational conversations, and even dance offs. You know what we’re talking about—the eighth annual Rock Health Summit is just over a month away. Here are seven agenda highlights we're most excited for at this year's Summit.
Better health, gut first: Our investment in Vivante Health
We're proud to announce our newest investment in Vivante Health, the first all-in-one digital solution for digestive health and complex inflammatory conditions. Welcome, Vivante!
2019 Midyear digital health market update: Exits are heating up
$4.2B was invested in digital health through the first half of 2019. The sector continues to experience healthy growth—we still don’t see the telltale signs of an investment bubble. Here we take stock of the capital invested in digital health startups since 2011—$29.4B of which is waiting on liquidity. We examine two avenues to return this capital: public offerings and acquisition by large non-healthcare companies.
Nominate a patient, caregiver, or advocate to attend Rock Health Summit 2019
Do you know or care for someone with a chronic illness, disease, or injury whose health experience has been impacted by technology? Their voices are integral to the conversations we have at Rock Health Summit. Like last year, we’re excited and honored to offer a handful of nominees complimentary passes to our eighth annual event.
Innovation in treating chronic pain requires new measures
As a second state pursues legal action against makers and distributors of opioid painkillers, the focus has continued to be on overdose deaths from prescription opioids, now averaging 46 per day. Often overlooked in this conversation is the broader epidemic—the 50M U.S. adults who suffer from chronic pain, of which, more than 19.6M Americans are thought to have high-impact chronic pain (i.e., pain that frequently limits life or work activities).
Podcast: Navigating pharma-digital therapeutic alliances
The industry is at a unique crossroads: pharmaceutical and digital therapeutic (DTx) companies have begun to act on their ambition to advance digital therapeutics—but the path to successful alliances and, importantly, scale remains uncertain. As a follow up to our recent research on building pharma-DTx alliances, we sat down with two leaders to get their perspective
Join our mailing list.
The most popular digital health newsletter. Subscribe to the Rock Weekly to be the first to know about our newest reports.